Searchable abstracts of presentations at key conferences in endocrinology

ea0034p290 | Pituitary | SFEBES2014

Newer dopaminergic agents cause minimal endocrine effects in subjects with idiopathic Parkinson's disease

Daniel J , Govindan J , Kamath C , De souza C , Adlan M A , Premawardhana L D

Objective: We studied the prevalence of endocrine dysfunction in subjects with idiopathic Parkinson’s disease (IPD) on newer dopaminergic agents (DA). DA are used in endocrine hypersecretory states in small doses and we hypothesized that endocrine dysfunction was likely in IPD where DA was used in comparatively much higher dosage.Patients and methods: 25 subjects with IPD on DA for were recruited to this cross-sectional study. We measured IGF1, prol...